NewAmsterdam Pharma Co N.V. vs Aardvark Therapeutics, Inc., risk disclosures compared

2topics both disclose

3only NewAmsterdam Pharma Co N.V.

4only Aardvark Therapeutics, Inc.

What both disclose

Topics appearing in filings from both companies, and how many filings each.

Topic	NewAmsterdam Pharma Co N.V.	Aardvark Therapeutics, Inc.
Cross Border Data Transfer	7	3
Business Continuity	1	7

Only NewAmsterdam Pharma Co N.V.

Topic	Filings
Internal Control	3
Material Weakness	2
Restatement	1

Only Aardvark Therapeutics, Inc.

Topic	Filings
Ransomware	4
Data Residency	3
Audit Committee Oversight	2
ESG Reporting	1

What this compares

Which of the topics we track appear in each company's SEC filings, and how often. A topic appearing for one company and not the other means one wrote the phrase down and the other did not, in the filings we hold. It does not mean one faces a risk the other does not, and it is not a comparison of how well either manages anything.

Counts reflect the filings we have collected, which is a growing subset rather than a company's complete history.

NewAmsterdam Pharma Co N.V. · Aardvark Therapeutics, Inc. · All companies